J Natl Compr Canc Netw. 2018 Dec;16(12):1451-1457. doi: 10.6004/jnccn.2018.7067.
Timely detection and treatment of breast cancer is important in optimizing survival and minimizing recurrence. Given disparities in breast cancer outcomes based on socioeconomic status, we examined time to diagnosis and treatment in a safety-net hospital. : We conducted a retrospective review of all patients with breast cancer diagnosed between July 1, 2010, and June 30, 2012 (N=120). We limited our analytic sample to patients with nonrecurrent, primary stage 0-III breast cancer (N=105) and determined intervals from presentation to diagnosis, diagnosis to first treatment, last surgery to chemotherapy initiation, and last surgery to start of radiation therapy (RT). Using logistic regression, we calculated unadjusted odds of receiving timely treatment (< median time) versus more delayed treatment (≥ median time) as a function of age, language, ethnicity, insurance, Charlson comorbidity index, disease stage, method of first presentation (screening mammography vs care provider), symptoms at presentation, and type of surgical treatment. Patients aged 55 to 64 years accounted for most of the sample (n=37; 35.2%). Median time from presentation to diagnosis (23 days), time from diagnosis to first treatment, and time from surgery to chemotherapy initiation fell within intervals published in the literature; median time from last surgery to start of RT was greater than recommended intervals. Factors significantly associated with longer intervals than median time included stage, method of presentation, language, surgical treatment, insurance, and ethnicity. Patients in this safety-net setting experienced acceptable diagnosis and treatment intervals, except for time to RT. Focused interventions that help care providers access imaging quickly for their symptomatic patients could improve time to diagnosis. Concentrating additional efforts on non-English-speaking, Hispanic patients and those who need to receive RT could improve time to treatment.
及时发现和治疗乳腺癌对于优化生存和最小化复发非常重要。鉴于乳腺癌结局存在社会经济地位方面的差异,我们研究了一家医保医院的诊断和治疗时间。我们对 2010 年 7 月 1 日至 2012 年 6 月 30 日期间诊断为乳腺癌的所有患者(N=120)进行了回顾性研究。我们将分析样本限定为非复发性、原发性 0-III 期乳腺癌患者(N=105),并确定从就诊到诊断、诊断到首次治疗、最后一次手术到开始化疗以及最后一次手术到开始放疗的时间间隔。使用逻辑回归,我们根据年龄、语言、种族、保险、Charlson 合并症指数、疾病分期、首次就诊方式(筛查性乳房 X 线摄影术与医疗服务提供者)、就诊时的症状以及手术治疗类型,计算接受及时治疗(<中位时间)与更延迟治疗(≥中位时间)的未经调整优势比。55 岁至 64 岁的患者占样本量的大多数(n=37;35.2%)。从就诊到诊断(23 天)、从诊断到首次治疗以及从手术到开始化疗的中位时间均在文献报道的时间范围内;从最后一次手术到开始放疗的中位时间长于推荐的时间间隔。与中位时间相比,时间更长的显著相关因素包括分期、就诊方式、语言、手术治疗、保险和种族。在这个医保环境中,患者的诊断和治疗时间可接受,除了放疗时间。针对帮助医疗服务提供者为其有症状的患者快速获取影像学检查的重点干预措施可能会改善诊断时间。集中精力针对非英语患者、西班牙语裔患者以及需要接受放疗的患者,可能会改善治疗时间。